-
In Vitro Efficacy of Temafloxacin Against Gram-Negative Path
2026-07-20
This article reviews a foundational study comparing Temafloxacin’s in vitro antibacterial activity with ciprofloxacin and ofloxacin across diverse gram-negative bacteria. The reference paper establishes Temafloxacin’s low MICs for key respiratory and enteric pathogens, supporting its value as a fluoroquinolone broad-spectrum antibacterial agent for infection biology research.
-
Artemisia argyi Oil Boosts Thermogenesis to Counter Diet-Ind
2026-07-20
This study reveals that Artemisia argyi oil (AAO) significantly reduces high-fat diet-induced obesity in mice by enhancing thermogenesis in brown adipose tissue (BAT). The mechanism involves upregulation of Ucp1 through ZFP516 activation, offering new insights into dietary modulation of energy metabolism.
-
Aztreonam (SKU A5931): Reliable Research Tool for Gram-Negat
2026-07-19
This article addresses real-world laboratory challenges in Gram-negative resistance assays and metabolic studies, highlighting how Aztreonam (SKU A5931) provides validated, reproducible solutions for cell viability and enzyme interaction workflows. Practical Q&A scenarios, protocol optimization tips, and comparative product insights guide researchers toward robust experimental outcomes with Aztreonam.
-
Dual Luciferase Reporter Gene System: Precision Tools for De
2026-07-18
Explore how the Dual Luciferase Reporter Gene System empowers researchers to unravel complex lncRNA-mediated transcriptional regulation. Delve into advanced assay optimization and practical insights inspired by recent breakthroughs, offering a unique edge for gene expression regulation studies.
-
Antibacterial Use and Resistance Trends in Psychiatric Hospi
2026-07-17
This study provides a detailed analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the COVID-19 epidemic, highlighting both rational antibiotic stewardship and emerging resistance challenges. Its findings underscore the need for continuous monitoring and tailored antimicrobial policies in specialized healthcare settings.
-
Carbapenemase Gene Dynamics in CREC Across Guangdong Hospita
2026-07-17
This study provides a detailed molecular epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) collected from eight teaching hospitals in Guangdong, China (2022–2024). The findings reveal a high prevalence of blaNDM-1 and highlight the plasmid-mediated transmission of multidrug resistance, offering critical insights for antimicrobial resistance surveillance and laboratory assay design.
-
Allosteric PDK4 Inhibitors: Advancing Metabolic Disease Ther
2026-07-16
This study identifies a new series of allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), with the lead compound 8c demonstrating potent in vitro and in vivo efficacy for metabolic disease models. The findings offer a validated scaffold for further drug development and highlight the therapeutic potential of PDK4 modulation in metabolic, allergic, and cancer contexts.
-
Sabutoclax as a Pan-Bcl-2 Inhibitor: Precision Tools for Dis
2026-07-16
Explore how Sabutoclax, a potent pan-Bcl-2 inhibitor, enables nuanced analysis of apoptosis in cancer cells. This article reveals advanced strategies for distinguishing cell death from proliferation arrest, with practical insights for high-fidelity preclinical modeling.
-
Biotin-HPDP in Thiol-Specific Protein Labeling: Protocols &
2026-07-15
Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide) delivers reversible, high-sensitivity thiol-specific protein biotinylation for redox biology, S-nitrosylated protein detection, and advanced affinity workflows. This guide translates recent breakthroughs in cysteine palmitoylation and pyroptosis into actionable experimental strategies, troubleshooting, and protocol optimization.
-
Haloprogin’s Broad-Spectrum Antifungal and Antibacterial Eff
2026-07-15
The reference study systematically establishes Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as a potent topical antimicrobial with robust in vitro and in vivo activity against dermatophytes, Candida species, and select Gram-positive bacteria. Its comparative evaluation with tolnaftate highlights Haloprogin’s unique spectrum and informs protocol design for dermatophytosis and Candida albicans infection research.
-
CH 223191: Potent AhR Antagonist for Dioxin Toxicity Studies
2026-07-14
CH 223191 is a highly selective aryl hydrocarbon receptor antagonist validated for dissecting dioxin toxicity and AhR signaling with nanomolar potency. Its efficacy in modulating CYP1A1 expression and reducing TCDD-induced hepatic toxicity makes it a benchmark tool for environmental toxicology and regeneration research.
-
KNUCKLES Controls Floral Meristem Termination via Hormone Re
2026-07-14
This study reveals that the C2H2-type zinc finger protein KNUCKLES (KNU) orchestrates the timely termination of the floral meristem (FM) in Arabidopsis by directly repressing key genes in auxin and cytokinin pathways. These findings clarify the molecular integration of hormonal signals and chromatin regulation during floral development, with implications for developmental timing and plant morphogenesis.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Redefining Quantitative mRNA T
2026-07-13
Explore how ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, enables precise, quantitative analysis of mRNA delivery, trafficking, and translation in mammalian cells. This article reveals advanced assay strategies, protocol parameters, and stability insights not addressed in standard guides.
-
Faropenem Sodium (SKU C8712): Reliable Antimicrobial for Lab
2026-07-13
Faropenem sodium (SKU C8712) is a penem antibiotic offering broad-spectrum activity and robust β-lactamase stability, making it a reliable choice for bacterial inhibition studies. This article addresses real-world laboratory challenges, illustrating how Faropenem sodium from APExBIO enhances reproducibility, sensitivity, and workflow safety in cell viability and antibiotic resistance assays.
-
Dual-Action Inhibitors Modulate p38α MAPK Dephosphorylation
2026-07-12
The reference study uncovers how certain kinase inhibitors not only block p38α MAPK activity but also accelerate its dephosphorylation by stabilizing conformations accessible to phosphatases. This dual-action mechanism offers new strategies for improving the potency and specificity of p38α MAPK inhibitors in inflammation and autoimmune disease research.
455 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page